Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 371

Similar articles for PubMed (Select 18565400)

1.

Thrombus precursor protein and clinical outcomes in patients with acute coronary syndromes.

Mega JL, Morrow DA, de Lemos JA, Mohanavelu S, Cannon CP, Sabatine MS.

J Am Coll Cardiol. 2008 Jun 24;51(25):2422-9. doi: 10.1016/j.jacc.2008.01.069.

2.
3.

A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.

Tello-Montoliu A, Marín F, Roldán V, Mainar L, López MT, Sogorb F, Vicente V, Lip GY.

J Intern Med. 2007 Dec;262(6):651-8. Epub 2007 Nov 7.

PMID:
17986200
4.

Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome.

Eggers KM, Lagerqvist B, Venge P, Wallentin L, Lindahl B.

J Am Coll Cardiol. 2009 Jul 21;54(4):357-64. doi: 10.1016/j.jacc.2009.03.056.

5.

Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z trial.

de Lemos JA, Morrow DA, Blazing MA, Jarolim P, Wiviott SD, Sabatine MS, Califf RM, Braunwald E.

J Am Coll Cardiol. 2007 Nov 27;50(22):2117-24. Epub 2007 Nov 13.

6.

N-terminal B-type natriuretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission.

Weber M, Bazzino O, Navarro Estrada JL, Fuselli JJ, Botto F, Perez de Arenaza D, Möllmann H, Nef HN, Elsässer A, Hamm CW.

J Am Coll Cardiol. 2008 Mar 25;51(12):1188-95. doi: 10.1016/j.jacc.2007.11.054.

7.
8.

Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.

O'Donoghue M, de Lemos JA, Morrow DA, Murphy SA, Buros JL, Cannon CP, Sabatine MS.

Circulation. 2006 Aug 8;114(6):550-7. Epub 2006 Jul 31.

9.

Heart-type fatty acid-binding protein predicts long-term mortality and re-infarction in consecutive patients with suspected acute coronary syndrome who are troponin-negative.

Viswanathan K, Kilcullen N, Morrell C, Thistlethwaite SJ, Sivananthan MU, Hassan TB, Barth JH, Hall AS.

J Am Coll Cardiol. 2010 Jun 8;55(23):2590-8. doi: 10.1016/j.jacc.2009.12.062.

10.

Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.

Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K.

Circulation. 2009 Jun 30;119(25):3181-8. doi: 10.1161/CIRCULATIONAHA.108.806877. Epub 2009 Jun 15.

11.

Impaired endogenous thrombolysis in acute coronary syndrome patients predicts cardiovascular death and nonfatal myocardial infarction.

Saraf S, Christopoulos C, Salha IB, Stott DJ, Gorog DA.

J Am Coll Cardiol. 2010 May 11;55(19):2107-15. doi: 10.1016/j.jacc.2010.01.033.

12.

Clinical correlation of multiple biomarkers for risk assessment in patients with acute coronary syndrome.

Narain VS, Gupta N, Sethi R, Puri A, Dwivedi SK, Saran RK, Puri VK.

Indian Heart J. 2008 Nov-Dec;60(6):536-42.

PMID:
19276492
13.

Interleukin-18: an independent predictor of cardiovascular events in patients with acute coronary syndrome after 6 months of follow-up.

Furtado MV, Rossini AP, Campani RB, Meotti C, Segatto M, Vietta G, Polanczyk CA.

Coron Artery Dis. 2009 Aug;20(5):327-331.

PMID:
19593889
14.

Soluble CD40L: risk prediction after acute coronary syndromes.

Varo N, de Lemos JA, Libby P, Morrow DA, Murphy SA, Nuzzo R, Gibson CM, Cannon CP, Braunwald E, Schönbeck U.

Circulation. 2003 Sep 2;108(9):1049-52. Epub 2003 Aug 11.

15.

Assessment of multiple cardiac biomarkers in non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 trial.

Scirica BM, Sabatine MS, Jarolim P, Murphy SA, de Lemos JL, Braunwald E, Morrow DA.

Eur Heart J. 2011 Mar;32(6):697-705. doi: 10.1093/eurheartj/ehq468. Epub 2010 Dec 22.

16.

Cardiac troponin I levels and clinical outcomes in patients with acute coronary syndromes: the potential role of early percutaneous revascularization.

Fuchs S, Kornowski R, Mehran R, Satler LF, Pichard AD, Kent KM, Hong MK, Slack S, Stone GW, Leon MB.

J Am Coll Cardiol. 1999 Nov 15;34(6):1704-10.

17.

Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values.

Kilcullen N, Viswanathan K, Das R, Morrell C, Farrin A, Barth JH, Hall AS; EMMACE-2 Investigators.

J Am Coll Cardiol. 2007 Nov 20;50(21):2061-7. Epub 2007 Nov 5.

18.

Concentrations of C-reactive protein and B-type natriuretic peptide 30 days after acute coronary syndromes independently predict hospitalization for heart failure and cardiovascular death.

Scirica BM, Cannon CP, Sabatine MS, Jarolim P, Sloane S, Rifai N, Braunwald E, Morrow DA; PROVE IT-TIMI 22 Investigators.

Clin Chem. 2009 Feb;55(2):265-73. doi: 10.1373/clinchem.2008.117192. Epub 2008 Dec 12.

19.

Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.

Omland T, Ueland T, Jansson AM, Persson A, Karlsson T, Smith C, Herlitz J, Aukrust P, Hartford M, Caidahl K.

J Am Coll Cardiol. 2008 Feb 12;51(6):627-33. doi: 10.1016/j.jacc.2007.09.058.

20.

C-reactive protein, interleukin-6, secretory phospholipase A2 group IIA and intercellular adhesion molecule-1 in the prediction of late outcome events after acute coronary syndromes.

Hartford M, Wiklund O, Mattsson Hultén L, Persson A, Karlsson T, Herlitz J, Caidahl K.

J Intern Med. 2007 Nov;262(5):526-36. Epub 2007 Oct 1.

PMID:
17908161
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk